# Delivery Order #SPE2DR26FQXL4

DMS Pharmaceutical Group Receives Xolair Autoinjector Delivery Order

**Buyer:** Defense Logistics Agency

**Award Amount:** $6,989.76
**Ceiling:** $6,989.76

**Awarded:** July 02, 2026
**Period of Performance:** Jul 02, 2026 - Jul 24, 2026

**Identifier:** SPE2DR26FQXL4
**NAICS:** 424210

This is a delivery order under DMS Pharmaceutical Group Inc.’s existing indefinite-delivery contract, for a supply of Xolair 150 mg/mL autoinjectors. DMS is a pharmaceutical supplier responsible for providing the medication; the order identifies Park Ridge, Illinois, as the place of performance. The purchase supports the agency’s access to a specified pharmaceutical product, though the award data does not identify the end users or broader clinical purpose. The order is associated with the parent contract for pharmaceutical products, which is described as competitively awarded; no competition details specific to this delivery order are provided. The parent contract runs from late 2025 into 2026, while this order is for a short, defined performance period in July 2026. No solicitation details, acquisition program, or subcontractor information are provided.

### Description

4572319509!XOLAIR 150 MG/ML AUTOINJECTORML

[View original record](https://www.usaspending.gov/award/CONT_AWD_SPE2DR26FQXL4_9700_SPE2DR25D9353_9700)
